お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、犬用鎮静剤の世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に犬用鎮静剤市場を分類しています。
本レポートでは世界の犬用鎮静剤市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：VetriScience、H&H Group、Vetoquinol、ThunderEase、Maxxidog、Heavenly Hounds、ElleVet Sciences、Wild One、FOMO Bones、Ark Naturals、Purina、Kradle、Zoetis、Pet Remedy、Ceva、Adaptil、Primo Pup、Penelope's Bloom、Extract Labs、Koi CBD、Elanco、Zatural、The Anxious Pet、This Dog's Life、NaturVet、King Kanine、Dr. Harvey’s、PetHonesty、Merck Animal Health、Boehringer Ingelheim、Shangrao Chunyu Technology、Shandong Youmi Le Health Technology

レポートは犬用鎮静剤の主要生産者を調査し、主要地域や国の消費状況も提供します。犬用鎮静剤の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Calming Supplements
    Pheromone Sprays
    Calming Collars
    Anxiety Vests

用途別の市場セグメント：
    Household
    Pet Hospitals and Clinics
    Pet Shop
    Others

本レポートの詳細内容
本レポートは、世界の犬用鎮静剤市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて犬用鎮静剤市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別（地域レベル、国レベル）の犬用鎮静剤生産量、成長率、市場シェアを調査している。

二. 消費面では、犬用鎮静剤の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーの犬用鎮静剤売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界の犬用鎮静剤市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本犬用鎮静剤のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：犬用鎮静剤のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2020～2031）
第2章： 犬用鎮静剤の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2020～2031）
第3章：世界、地域、国レベルにおける犬用鎮静剤の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2020～2031）
第4章犬用鎮静剤メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2020～2025）
第5章：犬用鎮静剤の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2020～2031）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2020～2031）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2020～2031）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第12章：犬用鎮静剤の主要メーカーの概要を提供し、製品の説明と仕様、犬用鎮静剤の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2020～2025）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：犬用鎮静剤の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

The global Calming Aids for Dogs market is projected to grow from US$ 568 million in 2025 to US$ 845 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period.
Canine sedatives refer to a class of drugs specifically used for canines, which are intended to calm, soothe or reduce anxiety through drug effects. Such drugs are usually used in veterinary clinical practice to help dogs stay calm during surgery, examination, treatment or specific stressful situations (such as travel, thunderstorm phobia, separation anxiety, etc.), reduce tension, fear or aggressive behavior, thereby ensuring the smooth progress of medical operations or improving animal welfare.
The market for canine sedatives has shown a steady growth trend in recent years, mainly benefiting from the booming pet economy and the significant increase in pet owners' attention to pet health and welfare. With the acceleration of urbanization and the improvement of people's living standards, the number of pet-raising families is increasing. As one of the most common pets, dogs have increasingly diversified medical needs, especially the use of sedatives, including surgical anesthesia assistance, behavior correction, travel comfort, etc. Current market dynamics show that technological innovation is the key to driving the development of the industry. The research and development of new sedatives focuses on safer, more efficient, and low-side effect products, such as drugs based on natural ingredients or targeted mechanisms of action, to meet the market's demand for pet-friendly medical solutions. At the same time, the strengthening of regulatory supervision has prompted companies to pay more attention to product quality and compliance, while the expansion of online sales channels and the digital transformation of pet medical services have also brought new growth points to the dog sedative market. It is expected that in the next few years, with the continued expansion of the pet medical market and the deepening of consumer awareness, the dog sedative market will maintain steady growth and develop in a more professional and refined direction.
In terms of consumption side, this report focuses on the sales of Calming Aids for Dogs by region (region level and country level), by company, by Type and by Application. from 2020 to 2025 and forecast to 2031.
This report presents an overview of global market for Calming Aids for Dogs, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Calming Aids for Dogs, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Calming Aids for Dogs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Calming Aids for Dogs sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Calming Aids for Dogs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. 
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Calming Aids for Dogs sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including VetriScience, H&H Group, Vetoquinol, ThunderEase, Maxxidog, Heavenly Hounds, ElleVet Sciences, Wild One, FOMO Bones, Ark Naturals, etc.

Market Segmentation
By Company
    VetriScience
    H&H Group
    Vetoquinol
    ThunderEase
    Maxxidog
    Heavenly Hounds
    ElleVet Sciences
    Wild One
    FOMO Bones
    Ark Naturals
    Purina
    Kradle
    Zoetis
    Pet Remedy
    Ceva
    Adaptil
    Primo Pup
    Penelope's Bloom
    Extract Labs
    Koi CBD
    Elanco
    Zatural
    The Anxious Pet
    This Dog's Life
    NaturVet
    King Kanine
    Dr. Harvey’s
    PetHonesty
    Merck Animal Health
    Boehringer Ingelheim
    Shangrao Chunyu Technology
    Shandong Youmi Le Health Technology

Segment by Type
    Calming Supplements
    Pheromone Sprays
    Calming Collars
    Anxiety Vests

Segment by Application
    Household
    Pet Hospitals and Clinics
    Pet Shop
    Others

Production by Region
    North America
    Europe
    China
    Japan

Sales by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
        Southeast Asia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia

Middle East, Africa, Latin America
        Brazil
        Mexico
        Turkey
        Israel

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Calming Aids for Dogs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Calming Aids for Dogs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Calming Aids for Dogs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
 Table 1. Global Calming Aids for Dogs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Major Manufacturers of Calming Supplements
 Table 3. Major Manufacturers of Pheromone Sprays
 Table 4. Major Manufacturers of Calming Collars
 Table 5. Major Manufacturers of Anxiety Vests
 Table 6. Global Calming Aids for Dogs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 7. Global Calming Aids for Dogs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 8. Global Revenue by Region (2020-2025) & (US$ Million)
 Table 9. Global Revenue Market Share by Region (2020-2031)
 Table 10. Global Calming Aids for Dogs Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Dose)
 Table 11. Global Calming Aids for Dogs Sales by Region (2020-2031) & (K Dose)
 Table 12. Global Sales Market Share by Region (2020-2031)
 Table 13. Global Calming Aids for Dogs Sales by Manufacturers (2020-2025) & (K Dose)
 Table 14. Global Calming Aids for Dogs Sales Share by Manufacturers (2020-2025)
 Table 15. Global Calming Aids for Dogs Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global Calming Aids for Dogs Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Players of Calming Aids for Dogs, Industry Ranking, 2023 VS 2024 VS 2024
 Table 18. Calming Aids for Dogs Price by Manufacturers (2020-2025) & (US$/Dose)
 Table 19. Global Calming Aids for Dogs Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 20. Global Calming Aids for Dogs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Calming Aids for Dogs as of 2024)
 Table 21. Global Key Manufacturers of Calming Aids for Dogs, Manufacturing Base Distribution and Headquarters
 Table 22. Global Key Manufacturers of Calming Aids for Dogs, Product Offered and Application
 Table 23. Global Key Manufacturers of Calming Aids for Dogs, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Calming Aids for Dogs Sales by Type (2020-2025) & (K Dose)
 Table 26. Global Calming Aids for Dogs Sales by Type (2026-2031) & (K Dose)
 Table 27. Global Sales Share by Type (2020-2031)
 Table 28. Global Calming Aids for Dogs Revenue by Type (2020-2025) & (US$ Million)
 Table 29. Global Calming Aids for Dogs Revenue by Type (2026-2031) & (US$ Million)
 Table 30. Global Revenue Share by Type (2020-2031)
 Table 31. Calming Aids for Dogs Price by Type (2020-2025) & (US$/Dose)
 Table 32. Global Calming Aids for Dogs Price Forecast by Type (2026-2031) & (US$/Dose)
 Table 33. Global Calming Aids for Dogs Sales by Application (2020-2025) & (K Dose)
 Table 34. Global Calming Aids for Dogs Sales by Application (2026-2031) & (K Dose)
 Table 35. Global Sales Share by Application (2020-2031)
 Table 36. Global Calming Aids for Dogs Revenue by Application (2020-2025) & (US$ Million)
 Table 37. Global Calming Aids for Dogs Revenue by Application (2026-2031) & (US$ Million)
 Table 38. Global Revenue Share by Application (2020-2031)
 Table 39. Calming Aids for Dogs Price by Application (2020-2025) & (US$/Dose)
 Table 40. Global Calming Aids for Dogs Price Forecast by Application (2026-2031) & (US$/Dose)
 Table 41. US & Canada Sales by Type (2020-2031) & (K Dose)
 Table 42. US & Canada Revenue by Type (2020-2031) & (US$ Million)
 Table 43. US & Canada Sales by Application (2020-2031) & (K Dose)
 Table 44. US & Canada Revenue by Application (2020-2031) & (US$ Million)
 Table 45. US & Canada Calming Aids for Dogs Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. US & Canada Revenue by Country (2020-2031) & (US$ Million)
 Table 47. US & Canada Sales by Country (2020-2031) & (K Dose)
 Table 48. Europe Sales by Type (2020-2031) & (K Dose)
 Table 49. Europe Revenue by Type (2020-2031) & (US$ Million)
 Table 50. Europe Sales by Application (2020-2031) & (K Dose)
 Table 51. Europe Revenue by Application (2020-2031) & (US$ Million)
 Table 52. Europe Calming Aids for Dogs Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 53. Europe Sales by Country (2020-2031) & (K Dose)
 Table 54. Europe Revenue by Country (2020-2031) & (US$ Million)
 Table 55. China Sales by Type (2020-2031) & (K Dose)
 Table 56. China Revenue by Type (2020-2031) & (US$ Million)
 Table 57. China Sales by Application (2020-2031) & (K Dose)
 Table 58. China Revenue by Application (2020-2031) & (US$ Million)
 Table 59. Asia Sales by Type (2020-2031) & (K Dose)
 Table 60. Asia Revenue by Type (2020-2031) & (US$ Million)
 Table 61. Asia Sales by Application (2020-2031) & (K Dose)
 Table 62. Asia Revenue by Application (2020-2031) & (US$ Million)
 Table 63. Asia Calming Aids for Dogs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 64. Asia Revenue by Region (2020-2031) & (US$ Million)
 Table 65. Asia Sales by Region (2020-2031) & (K Dose)
 Table 66. Middle East, Africa and Latin America Sales by Type (2020-2031) & (K Dose)
 Table 67. Middle East, Africa and Latin America Revenue by Type (2020-2031) & (US$ Million)
 Table 68. Middle East, Africa and Latin America Sales by Application (2020-2031) & (K Dose)
 Table 69. Middle East, Africa and Latin America Revenue by Application (2020-2031) & (US$ Million)
 Table 70. Middle East, Africa and Latin America Calming Aids for Dogs Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 71. Middle East, Africa and Latin America Revenue by Country (2020-2031) & (US$ Million)
 Table 72. Middle East, Africa and Latin America Sales by Country (2020-2031) & (K Dose)
 Table 73. VetriScience Company Information
 Table 74. VetriScience Description and Major Businesses
 Table 75. VetriScience Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 76. VetriScience Product Model Numbers, Pictures, Descriptions and Specifications
 Table 77. VetriScience Recent Developments
 Table 78. H&H Group Company Information
 Table 79. H&H Group Description and Major Businesses
 Table 80. H&H Group Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 81. H&H Group Product Model Numbers, Pictures, Descriptions and Specifications
 Table 82. H&H Group Recent Developments
 Table 83. Vetoquinol Company Information
 Table 84. Vetoquinol Description and Major Businesses
 Table 85. Vetoquinol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 86. Vetoquinol Product Model Numbers, Pictures, Descriptions and Specifications
 Table 87. Vetoquinol Recent Developments
 Table 88. ThunderEase Company Information
 Table 89. ThunderEase Description and Major Businesses
 Table 90. ThunderEase Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 91. ThunderEase Product Model Numbers, Pictures, Descriptions and Specifications
 Table 92. ThunderEase Recent Developments
 Table 93. Maxxidog Company Information
 Table 94. Maxxidog Description and Major Businesses
 Table 95. Maxxidog Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 96. Maxxidog Product Model Numbers, Pictures, Descriptions and Specifications
 Table 97. Maxxidog Recent Developments
 Table 98. Heavenly Hounds Company Information
 Table 99. Heavenly Hounds Description and Major Businesses
 Table 100. Heavenly Hounds Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 101. Heavenly Hounds Product Model Numbers, Pictures, Descriptions and Specifications
 Table 102. Heavenly Hounds Recent Developments
 Table 103. ElleVet Sciences Company Information
 Table 104. ElleVet Sciences Description and Major Businesses
 Table 105. ElleVet Sciences Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 106. ElleVet Sciences Product Model Numbers, Pictures, Descriptions and Specifications
 Table 107. ElleVet Sciences Recent Developments
 Table 108. Wild One Company Information
 Table 109. Wild One Description and Major Businesses
 Table 110. Wild One Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 111. Wild One Product Model Numbers, Pictures, Descriptions and Specifications
 Table 112. Wild One Recent Developments
 Table 113. FOMO Bones Company Information
 Table 114. FOMO Bones Description and Major Businesses
 Table 115. FOMO Bones Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 116. FOMO Bones Product Model Numbers, Pictures, Descriptions and Specifications
 Table 117. FOMO Bones Recent Developments
 Table 118. Ark Naturals Company Information
 Table 119. Ark Naturals Description and Major Businesses
 Table 120. Ark Naturals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 121. Ark Naturals Product Model Numbers, Pictures, Descriptions and Specifications
 Table 122. Ark Naturals Recent Developments
 Table 123. Purina Company Information
 Table 124. Purina Description and Major Businesses
 Table 125. Purina Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 126. Purina Product Model Numbers, Pictures, Descriptions and Specifications
 Table 127. Purina Recent Developments
 Table 128. Kradle Company Information
 Table 129. Kradle Description and Major Businesses
 Table 130. Kradle Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 131. Kradle Product Model Numbers, Pictures, Descriptions and Specifications
 Table 132. Kradle Recent Developments
 Table 133. Zoetis Company Information
 Table 134. Zoetis Description and Major Businesses
 Table 135. Zoetis Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 136. Zoetis Product Model Numbers, Pictures, Descriptions and Specifications
 Table 137. Zoetis Recent Developments
 Table 138. Pet Remedy Company Information
 Table 139. Pet Remedy Description and Major Businesses
 Table 140. Pet Remedy Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 141. Pet Remedy Product Model Numbers, Pictures, Descriptions and Specifications
 Table 142. Pet Remedy Recent Developments
 Table 143. Ceva Company Information
 Table 144. Ceva Description and Major Businesses
 Table 145. Ceva Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 146. Ceva Product Model Numbers, Pictures, Descriptions and Specifications
 Table 147. Ceva Recent Developments
 Table 148. Adaptil Company Information
 Table 149. Adaptil Description and Major Businesses
 Table 150. Adaptil Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 151. Adaptil Product Model Numbers, Pictures, Descriptions and Specifications
 Table 152. Adaptil Recent Developments
 Table 153. Primo Pup Company Information
 Table 154. Primo Pup Description and Major Businesses
 Table 155. Primo Pup Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 156. Primo Pup Product Model Numbers, Pictures, Descriptions and Specifications
 Table 157. Primo Pup Recent Developments
 Table 158. Penelope's Bloom Company Information
 Table 159. Penelope's Bloom Description and Major Businesses
 Table 160. Penelope's Bloom Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 161. Penelope's Bloom Product Model Numbers, Pictures, Descriptions and Specifications
 Table 162. Penelope's Bloom Recent Developments
 Table 163. Extract Labs Company Information
 Table 164. Extract Labs Description and Major Businesses
 Table 165. Extract Labs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 166. Extract Labs Product Model Numbers, Pictures, Descriptions and Specifications
 Table 167. Extract Labs Recent Developments
 Table 168. Koi CBD Company Information
 Table 169. Koi CBD Description and Major Businesses
 Table 170. Koi CBD Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 171. Koi CBD Product Model Numbers, Pictures, Descriptions and Specifications
 Table 172. Koi CBD Recent Developments
 Table 173. Elanco Company Information
 Table 174. Elanco Description and Major Businesses
 Table 175. Elanco Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 176. Elanco Product Model Numbers, Pictures, Descriptions and Specifications
 Table 177. Elanco Recent Developments
 Table 178. Zatural Company Information
 Table 179. Zatural Description and Major Businesses
 Table 180. Zatural Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 181. Zatural Product Model Numbers, Pictures, Descriptions and Specifications
 Table 182. Zatural Recent Developments
 Table 183. The Anxious Pet Company Information
 Table 184. The Anxious Pet Description and Major Businesses
 Table 185. The Anxious Pet Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 186. The Anxious Pet Product Model Numbers, Pictures, Descriptions and Specifications
 Table 187. The Anxious Pet Recent Developments
 Table 188. This Dog's Life Company Information
 Table 189. This Dog's Life Description and Major Businesses
 Table 190. This Dog's Life Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 191. This Dog's Life Product Model Numbers, Pictures, Descriptions and Specifications
 Table 192. This Dog's Life Recent Developments
 Table 193. NaturVet Company Information
 Table 194. NaturVet Description and Major Businesses
 Table 195. NaturVet Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 196. NaturVet Product Model Numbers, Pictures, Descriptions and Specifications
 Table 197. NaturVet Recent Developments
 Table 198. King Kanine Company Information
 Table 199. King Kanine Description and Major Businesses
 Table 200. King Kanine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 201. King Kanine Product Model Numbers, Pictures, Descriptions and Specifications
 Table 202. King Kanine Recent Developments
 Table 203. Dr. Harvey’s Company Information
 Table 204. Dr. Harvey’s Description and Major Businesses
 Table 205. Dr. Harvey’s Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 206. Dr. Harvey’s Product Model Numbers, Pictures, Descriptions and Specifications
 Table 207. Dr. Harvey’s Recent Developments
 Table 208. PetHonesty Company Information
 Table 209. PetHonesty Description and Major Businesses
 Table 210. PetHonesty Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 211. PetHonesty Product Model Numbers, Pictures, Descriptions and Specifications
 Table 212. PetHonesty Recent Developments
 Table 213. Merck Animal Health Company Information
 Table 214. Merck Animal Health Description and Major Businesses
 Table 215. Merck Animal Health Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 216. Merck Animal Health Product Model Numbers, Pictures, Descriptions and Specifications
 Table 217. Merck Animal Health Recent Developments
 Table 218. Boehringer Ingelheim Company Information
 Table 219. Boehringer Ingelheim Description and Major Businesses
 Table 220. Boehringer Ingelheim Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 221. Boehringer Ingelheim Product Model Numbers, Pictures, Descriptions and Specifications
 Table 222. Boehringer Ingelheim Recent Developments
 Table 223. Shangrao Chunyu Technology Company Information
 Table 224. Shangrao Chunyu Technology Description and Major Businesses
 Table 225. Shangrao Chunyu Technology Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 226. Shangrao Chunyu Technology Product Model Numbers, Pictures, Descriptions and Specifications
 Table 227. Shangrao Chunyu Technology Recent Developments
 Table 228. Shandong Youmi Le Health Technology Company Information
 Table 229. Shandong Youmi Le Health Technology Description and Major Businesses
 Table 230. Shandong Youmi Le Health Technology Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 231. Shandong Youmi Le Health Technology Product Model Numbers, Pictures, Descriptions and Specifications
 Table 232. Shandong Youmi Le Health Technology Recent Developments
 Table 233. Key Raw Materials Lists
 Table 234. Raw Materials Key Suppliers Lists
 Table 235. Distributors List
 Table 236. Customers List
 Table 237. Market Trends
 Table 238. Market Drivers
 Table 239. Market Challenges
 Table 240. Market Restraints
 Table 241. Research Programs/Design for This Report
 Table 242. Key Data Information from Secondary Sources
 Table 243. Key Data Information from Primary Sources


List of Figures
 Figure 1. Calming Aids for Dogs Product Picture
 Figure 2. Global Calming Aids for Dogs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Calming Aids for Dogs Market Share by Type: 2024 & 2031
 Figure 4. Calming Supplements Product Picture
 Figure 5. Pheromone Sprays Product Picture
 Figure 6. Calming Collars Product Picture
 Figure 7. Anxiety Vests Product Picture
 Figure 8. Global Calming Aids for Dogs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 9. Global Calming Aids for Dogs Market Share by Application: 2024 & 2031
 Figure 10. Household
 Figure 11. Pet Hospitals and Clinics
 Figure 12. Pet Shop
 Figure 13. Others
 Figure 14. Calming Aids for Dogs Report Years Considered
 Figure 15. Global Calming Aids for Dogs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Calming Aids for Dogs Revenue (2020-2031) & (US$ Million)
 Figure 17. Global Calming Aids for Dogs Revenue by Region (2020-2031) (US$ Million)
 Figure 18. Global Calming Aids for Dogs Revenue Market Share by Region in Percentage: 2024 Versus 2031
 Figure 19. Global Calming Aids for Dogs Revenue Market Share by Region (2020-2031)
 Figure 20. Global Calming Aids for Dogs Sales (2020-2031) & (K Dose)
 Figure 21. Global Calming Aids for Dogs Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (K Dose)
 Figure 22. Global Calming Aids for Dogs Sales Market Share by Region (2020-2031)
 Figure 23. US & Canada Calming Aids for Dogs Sales YoY (2020-2031) & (K Dose)
 Figure 24. US & Canada Calming Aids for Dogs Revenue YoY (2020-2031) & (US$ Million)
 Figure 25. Europe Calming Aids for Dogs Sales YoY (2020-2031) & (K Dose)
 Figure 26. Europe Calming Aids for Dogs Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. China Calming Aids for Dogs Sales YoY (2020-2031) & (K Dose)
 Figure 28. China Calming Aids for Dogs Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. Asia (excluding China) Calming Aids for Dogs Sales YoY (2020-2031) & (K Dose)
 Figure 30. Asia (excluding China) Calming Aids for Dogs Revenue YoY (2020-2031) & (US$ Million)
 Figure 31. Middle East, Africa and Latin America Calming Aids for Dogs Sales YoY (2020-2031) & (K Dose)
 Figure 32. Middle East, Africa and Latin America Calming Aids for Dogs Revenue YoY (2020-2031) & (US$ Million)
 Figure 33. Global Calming Aids for Dogs Sales Share by Manufacturers (2024)
 Figure 34. The Calming Aids for Dogs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024
 Figure 35. Global Calming Aids for Dogs Revenue Share by Manufacturers (2024)
 Figure 36. The Top 5 and 10 Largest Manufacturers of Calming Aids for Dogs in the World: Market Share by Calming Aids for Dogs Revenue in 2024
 Figure 37. Global Calming Aids for Dogs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 38. Global Calming Aids for Dogs Sales Market Share by Type (2020-2031)
 Figure 39. Global Calming Aids for Dogs Revenue Market Share by Type (2020-2031)
 Figure 40. Global Calming Aids for Dogs Sales Market Share by Application (2020-2031)
 Figure 41. Global Calming Aids for Dogs Revenue Market Share by Application (2020-2031)
 Figure 42. US & Canada Calming Aids for Dogs Sales Market Share by Type (2020-2031)
 Figure 43. US & Canada Calming Aids for Dogs Revenue Market Share by Type (2020-2031)
 Figure 44. US & Canada Calming Aids for Dogs Sales Market Share by Application (2020-2031)
 Figure 45. US & Canada Calming Aids for Dogs Revenue Market Share by Application (2020-2031)
 Figure 46. US & Canada Calming Aids for Dogs Revenue Share by Country (2020-2031)
 Figure 47. US & Canada Calming Aids for Dogs Sales Share by Country (2020-2031)
 Figure 48. US Calming Aids for Dogs Revenue (2020-2031) & (US$ Million)
 Figure 49. Canada Calming Aids for Dogs Revenue (2020-2031) & (US$ Million)
 Figure 50. Europe Calming Aids for Dogs Sales Market Share by Type (2020-2031)
 Figure 51. Europe Calming Aids for Dogs Revenue Market Share by Type (2020-2031)
 Figure 52. Europe Calming Aids for Dogs Sales Market Share by Application (2020-2031)
 Figure 53. Europe Calming Aids for Dogs Revenue Market Share by Application (2020-2031)
 Figure 54. Europe Calming Aids for Dogs Sales Share by Country (2020-2031)
 Figure 55. Europe Calming Aids for Dogs Revenue Share by Country (2020-2031)
 Figure 56. Germany Calming Aids for Dogs Revenue (2020-2031) & (US$ Million)
 Figure 57. France Calming Aids for Dogs Revenue (2020-2031) & (US$ Million)
 Figure 58. U.K. Calming Aids for Dogs Revenue (2020-2031) & (US$ Million)
 Figure 59. Italy Calming Aids for Dogs Revenue (2020-2031) & (US$ Million)
 Figure 60. Russia Calming Aids for Dogs Revenue (2020-2031) & (US$ Million)
 Figure 61. China Calming Aids for Dogs Sales Market Share by Type (2020-2031)
 Figure 62. China Calming Aids for Dogs Revenue Market Share by Type (2020-2031)
 Figure 63. China Calming Aids for Dogs Sales Market Share by Application (2020-2031)
 Figure 64. China Calming Aids for Dogs Revenue Market Share by Application (2020-2031)
 Figure 65. Asia Calming Aids for Dogs Sales Market Share by Type (2020-2031)
 Figure 66. Asia Calming Aids for Dogs Revenue Market Share by Type (2020-2031)
 Figure 67. Asia Calming Aids for Dogs Sales Market Share by Application (2020-2031)
 Figure 68. Asia Calming Aids for Dogs Revenue Market Share by Application (2020-2031)
 Figure 69. Asia Calming Aids for Dogs Revenue Share by Region (2020-2031)
 Figure 70. Asia Calming Aids for Dogs Sales Share by Region (2020-2031)
 Figure 71. Japan Calming Aids for Dogs Revenue (2020-2031) & (US$ Million)
 Figure 72. South Korea Calming Aids for Dogs Revenue (2020-2031) & (US$ Million)
 Figure 73. China Taiwan Calming Aids for Dogs Revenue (2020-2031) & (US$ Million)
 Figure 74. Southeast Asia Calming Aids for Dogs Revenue (2020-2031) & (US$ Million)
 Figure 75. India Calming Aids for Dogs Revenue (2020-2031) & (US$ Million)
 Figure 76. Australia Calming Aids for Dogs Revenue (2020-2031) & (US$ Million)
 Figure 77. Middle East, Africa and Latin America Calming Aids for Dogs Sales Market Share by Type (2020-2031)
 Figure 78. Middle East, Africa and Latin America Calming Aids for Dogs Revenue Market Share by Type (2020-2031)
 Figure 79. Middle East, Africa and Latin America Calming Aids for Dogs Sales Market Share by Application (2020-2031)
 Figure 80. Middle East, Africa and Latin America Calming Aids for Dogs Revenue Market Share by Application (2020-2031)
 Figure 81. Middle East, Africa and Latin America Calming Aids for Dogs Revenue Share by Country (2020-2031)
 Figure 82. Middle East, Africa and Latin America Calming Aids for Dogs Sales Share by Country (2020-2031)
 Figure 83. Brazil Calming Aids for Dogs Revenue (2020-2031) & (US$ Million)
 Figure 84. Mexico Calming Aids for Dogs Revenue (2020-2031) & (US$ Million)
 Figure 85. Turkey Calming Aids for Dogs Revenue (2020-2031) & (US$ Million)
 Figure 86. Israel Calming Aids for Dogs Revenue (2020-2031) & (US$ Million)
 Figure 87. GCC Countries Calming Aids for Dogs Revenue (2020-2031) & (US$ Million)
 Figure 88. Value Chain
 Figure 89. Calming Aids for Dogs Production Process
 Figure 90. Channels of Distribution (Direct Vs Distribution)
 Figure 91. Bottom-up and Top-down Approaches for This Report
 Figure 92. Data Triangulation
 Figure 93. Key Executives Interviewed